Susquehanna International Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.61M | Buy |
191,900
+122,100
| +175% | +$1.28M | ﹤0.01% | 6682 |
|
|
2025
Q4 | $1.01M | Buy |
69,800
+59,600
| +584% | +$743K | ﹤0.01% | 7183 |
|
|
2025
Q3 | $98.4K | Buy |
+10,200
| New | +$90.2K | ﹤0.01% | 11574 |
|
|
2025
Q1 | – | Sell |
-14,400
| Closed | -$111K | – | 13296 |
|
|
2024
Q4 | $111K | Sell |
14,400
-25,300
| -64% | -$238K | ﹤0.01% | 11252 |
|
|
2024
Q3 | $416K | Buy |
39,700
+16,600
| +72% | +$202K | ﹤0.01% | 8903 |
|
|
2024
Q2 | $270K | Buy |
23,100
+12,100
| +110% | +$188K | ﹤0.01% | 9678 |
|
|
2024
Q1 | $232K | Sell |
11,000
-4,900
| -31% | -$87.2K | ﹤0.01% | 10276 |
|
|
2023
Q4 | $285K | Buy |
+15,900
| New | +$280K | ﹤0.01% | 9939 |
|
|
2023
Q3 | – | Sell |
-35,700
| Closed | -$714K | – | 12813 |
|
|
2023
Q2 | $714K | Buy |
35,700
+15,500
| +77% | +$299K | ﹤0.01% | 7474 |
|
|
2023
Q1 | $382K | Buy |
+20,200
| New | +$447K | ﹤0.01% | 9192 |
|
|
2022
Q4 | – | Sell |
-19,400
| Closed | -$513K | – | 13474 |
|
|
2022
Q3 | $513K | Sell |
19,400
-6,800
| -26% | -$202K | ﹤0.01% | 8419 |
|
|
2022
Q2 | $647K | Sell |
26,200
-23,900
| -48% | -$597K | ﹤0.01% | 7636 |
|
|
2022
Q1 | $1.66M | Sell |
50,100
-9,700
| -16% | -$269K | ﹤0.01% | 5889 |
|
|
2021
Q4 | $1.96M | Buy |
59,800
+34,000
| +132% | +$1.16M | ﹤0.01% | 5562 |
|
|
2021
Q3 | $1.08M | Buy |
25,800
+4,400
| +21% | +$158K | ﹤0.01% | 7348 |
|
|
2021
Q2 | $831K | Sell |
21,400
-31,700
| -60% | -$1.13M | ﹤0.01% | 8273 |
|
|
2021
Q1 | $1.81M | Sell |
53,100
-53,700
| -50% | -$2.29M | ﹤0.01% | 6160 |
|
|
2020
Q4 | $4.84M | Buy |
106,800
+84,300
| +375% | +$2.95M | ﹤0.01% | 3451 |
|
|
2020
Q3 | $619K | Sell |
22,500
-95,400
| -81% | -$3.11M | ﹤0.01% | 7230 |
|
|
2020
Q2 | $4.34M | Buy |
117,900
+6,400
| +6% | +$239K | ﹤0.01% | 3199 |
|
|
2020
Q1 | $3.61M | Buy |
111,500
+38,000
| +52% | +$1.58M | ﹤0.01% | 3008 |
|
|
2019
Q4 | $3.01M | Buy |
73,500
+7,200
| +11% | +$284K | ﹤0.01% | 3693 |
|
|
2019
Q3 | $2.36M | Buy |
66,300
+17,300
| +35% | +$701K | ﹤0.01% | 3883 |
|
|
2019
Q2 | $2.52M | Buy |
49,000
+22,500
| +85% | +$1.12M | ﹤0.01% | 3738 |
|
|
2019
Q1 | $1.52M | Sell |
26,500
-34,300
| -56% | -$1.7M | ﹤0.01% | 4218 |
|
|
2018
Q4 | $2.55M | Sell |
60,800
-7,600
| -11% | -$446K | ﹤0.01% | 3155 |
|
|
2018
Q3 | $5.16M | Sell |
68,400
-23,400
| -25% | -$1.69M | ﹤0.01% | 2659 |
|
|
2018
Q2 | $6.59M | Buy |
91,800
+80,200
| +691% | +$3.83M | ﹤0.01% | 2407 |
|
|
2018
Q1 | $346K | Sell |
11,600
-93,600
| -89% | -$2.72M | ﹤0.01% | 7379 |
|
|
2017
Q4 | $3.5M | Buy |
105,200
+92,700
| +742% | +$2.79M | ﹤0.01% | 3005 |
|
|
2017
Q3 | $412K | Buy |
+12,500
| New | +$281K | ﹤0.01% | 6855 |
|
Other funds holding RGNX
RG
VCM
IHAM
Susquehanna International Group's RGNX Position: Q1 2026 in Review
Susquehanna International Group increased its Regenxbio (RGNX) stake by 483% in Q1 2026, buying an estimated $793K and bringing the position to 91,084 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #8595.
Susquehanna International Group first reported a position in RGNX in Q2 2016 and has held it in 33 quarters since. The position peaked at $4.02M in Q3 2019. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Susquehanna International Group held 91,084 shares of Regenxbio worth $763K as of Q1 2026.
- Susquehanna International Group bought 75,460 Regenxbio shares in Q1 2026, an estimated $793K.
- Regenxbio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8595 holding.
- Susquehanna International Group first reported a position in Regenxbio in Q2 2016 and has held it in 33 quarters since.
- Susquehanna International Group's Regenxbio position peaked at $4.02M in Q3 2019.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.